Anika Therapeutics
ANIK
153 hedge funds and large institutions have $418M invested in Anika Therapeutics in 2014 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 58 increasing their positions, 52 reducing their positions, and 20 closing their positions.
122% more capital inflows, than outflows
Capital inflows: $90.3M | Capital outflows: $40.8M
35% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 20
12% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 52
9.4% more ownership
Funds ownership: 61.56% → 70.96% (+9.4%)
5% more funds holding
Funds holding: 146 → 153 (+7)
33% less call options, than puts
Call options by funds: $3.71M | Put options by funds: $5.55M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
+$18.9M |
| 2 |
Alberta Investment Management Corp (AIMCo)
Edmonton,
Alberta, Canada
|
+$6.86M |
| 3 |
Stephens Investment Management Group
Houston,
Texas
|
+$5.95M |
| 4 |
BlackRock Institutional Trust
San Francisco,
California
|
+$4.39M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$4.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
-$5.81M |
| 2 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
-$4.29M |
| 3 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$4.28M |
| 4 |
Bridgeway Capital Management
Houston,
Texas
|
-$2.31M |
| 5 |
Numeric Investors
Boston,
Massachusetts
|
-$1.56M |
ANIK Hedge Fund Activity: Q1 2014 in Review
153 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Anika Therapeutics (ANIK) for Q1 2014, worth a combined $418M — up 24% from $336M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new ANIK positions and 20 closed out — a net gain of 7 holders — while 58 added to existing stakes and 52 trimmed.
The largest buyer was Systematic Financial Management, adding an estimated $18.9M. The largest seller was Northpointe Capital, exiting entirely with an estimated $5.81M sold.
- 153 institutional investors held Anika Therapeutics (ANIK) as of Q1 2014, up from 146 in Q4 2013.
- Funds reported $418M of Anika Therapeutics stock for Q1 2014, up 24% quarter-over-quarter.
- 27 funds opened new Anika Therapeutics positions in Q1 2014 and 20 closed out, a net change of +7 holders.
- The largest Anika Therapeutics buyer in Q1 2014 was Systematic Financial Management, an estimated $18.9M added.
- The largest Anika Therapeutics seller in Q1 2014 was Northpointe Capital, an estimated $5.81M sold.
Based on aggregated 13F filings for Q1 2014.